Ophthalmology-focused publications and findings on COVID-19: A systematic review
العنوان: | Ophthalmology-focused publications and findings on COVID-19: A systematic review |
---|---|
المؤلفون: | Yvonne M. Buys, Ya-Ping Jin, Sherif El-Defrawy, Elin Y Liu, Graham E. Trope |
المصدر: | European Journal of Ophthalmology |
بيانات النشر: | SAGE Publications, 2021. |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Medical education, 2019-20 coronavirus outbreak, History, Coronavirus disease 2019 (COVID-19), SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transmission, Reviews, COVID-19, General Medicine, 03 medical and health sciences, Ophthalmology, Cross-Sectional Studies, 0302 clinical medicine, conjunctivitis, 030221 ophthalmology & optometry, Key (cryptography), Humans, 030212 general & internal medicine, publications, Pandemics, manifestation |
الوصف: | Purpose: To summarize COVID-19 research endeavors by ophthalmologists/researchers in terms of publication numbers, journals and author countries, and to detail key findings. Methods: The LitCovid database was systematically reviewed for ophthalmology-focused COVID-19 articles. The quality of the evidence was assessed for articles investigating conjunctivitis in COVID-19 patients. Results: There were 21,364 articles in LitCovid on June 12, 2020, of which 215 (1%) were ophthalmology-focused. Of articles on COVID-19 transmission, 3.3% were ophthalmology-focused. Ophthalmology-focused articles were published in 68 journals and originated from 25 countries. The top five countries publishing ophthalmology-focused articles (China, India, United States of America, Italy, and United Kingdom) produced 145/215 (67%) articles. A total of 16 case reports/series from eight countries reported that conjunctivitis can be the initial or the only symptom of COVID-19 infection. Conjunctivitis may occur in the middle phase of COVID-19 illness. A total of 10 hospital-based cross-sectional studies reported that between 0% and 31.6% of COVID-19 patients have conjunctivitis or other ocular conditions, with a pooled prevalence of 5.5% reported in a meta-analysis. Viral RNA was detected in conjunctival swabs of patients with and without ocular manifestations, after resolution of conjunctivitis, after nasopharyngeal swabs turned negative and in retina of deceased COVID-19 patients. Conclusion: Within 3 months of declaring the COVID-19 pandemic, 215 ophthalmology-focused articles were published in PubMed, concentrating on disease manifestations and transmission. The reported presence of conjunctivitis or other ocular conditions in COVID-19 patients is varied. Clinicians should be alert for ocular involvement in COVID-19 infections and possible ocular transmission even in patients without ocular symptoms. |
تدمد: | 1724-6016 1120-6721 |
DOI: | 10.1177/1120672121992949 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbdf1ec9c80f188eda5ed67d16b262f4 https://doi.org/10.1177/1120672121992949 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....fbdf1ec9c80f188eda5ed67d16b262f4 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 17246016 11206721 |
---|---|
DOI: | 10.1177/1120672121992949 |